Go to startpage Updates from Mölnlycke Mölnlycke latest news Current: Rethinking tissue viability services NURSING TIMES Rethinking tissue viability services It is estimated that the annual prevalence of wounds increased by 71% between 2012-2013 and 2017-2018, and feedback from wound care specialists suggests that services are frequently under pressure and at times overwhelmed. The way healthcare services are provided has changed significantly in response to the coronavirus pandemic; this has presented new opportunities for wound care – including access to remote assessment and monitoring – but it has also exposed barriers to improvement, such as a lack of wound care data. As the immediate health crisis subsides, and trusts rethink their services, how should these experiences inform wound care strategies in the future? Critical to achieving change is a partnership between directors of nursing and wound care specialists who understand the day-to-day challenges of providing effective patient care. This Nursing Times discussion document aims to support this partnership and provides a list of action points that directors of nursing need to consider when planning wound care services. These were drawn up following a roundtable discussion with directors of nursing and service leads; in addition, interviews were conducted with experts in the field of wound care. The document reviews the key problem facing wound care services, offers examples of best practice and highlights the support that services need to respond effectively to the growing problem of chronic wound management. The discussion document was funded by an unrestricted educational grant from Mölnlycke. We hope it will support senior nurses and wound care specialists to review services and plan effectively for the future. Download your copy Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. We use cookies to improve your use and experience of Mölnlycke’s websites. By continuing to browse Mölnlycke’s site(s), you consent to the use of cookies in accordance with Mölnlycke’s applicable policies . © 2021 Mölnlycke Health Care AB. All rights reserved. Get to know us About us Products and solutions Our knowledge External links Contact us Get the details Regulatory support Products - Instructions for use Policies Terms of use Cookie policy Follow us Attention: Products shown on the Mölnlycke web sites(s) may not be available in all markets and product indication claim(s) may vary between markets. The Mölnlycke, Alldress, Arthropad, Avance, BARRIER, Biogel, Biogel Eclipse, Biogel PI Pro-Fit, Biogel Sensor, Brevet TX, Collar'n'Cuff, Drisite Easywarm, Elset, Epaderm, Exufiber, Hydrolock, EZ Derm, Hacdil, Hibi, Hibiclens, Hibidil, HiBiscrub, Indicator, Lyofoam, Mefix, Melgisorb, Mextra, Mepiform, Mepilex, Mepiseal, Mepitac, Mepitel, Mepore, Mesalt, Mesoft, Mesorb, Mestopore, Micro Indicator, NeoDerm, Normlgel, PI Indicator, PI Micro Indicator, PI Ultratouch, Polysling, Previsense, Reveal, Safetac, Setopress, Skinsense, Slinky, Steripod, Sterets, Tisept, Tubifast, Tubifast 2-way stretch, Tubigrip, Tubinette, Unisept and Unisoft trademarks, names and logos are registered globally to one or more of the Mölnlycke Health Care group of companies. Cookies Cookies help us deliver our services and provide personalized experiences. By using this website, you agree to our use of cookies. You can opt out by clicking on the following link. I agree